A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This international, multi-center, randomized, double-blind, placebo-controlled Phase 3 trial
will study the safety, tolerability, and efficacy of bardoxolone methyl in qualified patients
with ADPKD. Approximately 300 patients will be enrolled.